GPT and liver disorder: The Fibrosis-4 index (FIB-4), using age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelet count, is a noninvasive tool that effectively identifies advanced fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) patients and has been shown to have a prognostic value for prediction of adverse outcomes [3,4].